Literature DB >> 25264244

Life-threatening hypophosphatemia and/or phosphate depletion in a patient with acute lymphoblastic leukemia: a rare case report.

Yasemin Soyoral1, Mehmet Aslan2, Senar Ebinc2, Yaren Dirik2, Cengiz Demir3.   

Abstract

Acute severe hypophosphatemia can be life threatening and is associated with mortality and impaired cardiac and respiratory function. Several conditions including decreased absorption or increased urinary phosphate excretion, shifts from the extracellular to intracellular compartments, and phosphate consumption by rapidly proliferating cells are known to induce moderate to severe acute hypophosphatemia. Although hypophosphatemia and/or phosphate depletion in patients with acute or chronic myeloid leukemia have been reported in the literature, hypophosphatemia due to acute lymphoblastic leukemia (ALL) is very rare. We report a case of history of ALL complicated by life-threatening hypophosphatemia manifesting as generalized muscle weakness, fatigue, acute shortness of breath, and difficulty in standing up and walking for 3 days. Serum inorganic phosphate levels were consistently low (0.06 mmol/L). The patient was hospitalized and thought to have a relapsed ALL.Anticancer agents and oral phosphate (660 mg twice daily) were administered. On the second day of treatment, the patient began to improve, and the patient gradually fully recovered within 5 days.We suggested that this hypophosphatemia was induced by a shift of phosphorus into leukemic cells that rapidly replicated in the tissues and excessive cellular phosphate consumption by rapidly proliferating cells. Serum phosphate levels should always be monitored,especially in suspected life-threatening manifestation in relapsed ALL.

Entities:  

Mesh:

Year:  2014        PMID: 25264244     DOI: 10.1016/j.ajem.2014.04.011

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

Review 1.  Bone resorption: supporting immunometabolism.

Authors:  Gustav van Niekerk; Megan Mitchell; Anna-Mart Engelbrecht
Journal:  Biol Lett       Date:  2018-02       Impact factor: 3.703

2.  Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.

Authors:  Xiao-Dan Luo; Shao-Jiang Yang; Jia-Ni Wang; Li Tan; Dan Liu; Ya-Ya Wang; Run-Hui Zheng; Xiao-Hong Wu; Li-Hua Xu; Huo Tan
Journal:  Tumour Biol       Date:  2015-12-17

3.  Association Between Low Serum Phosphate Level and Risk of Falls in Hospitalized Patients Over 50 Years of Age: A Retrospective Observational Cohort Study.

Authors:  Seol A Jang; Su Jin Kwon; Chul Sik Kim; Seok Won Park; Kyoung Min Kim
Journal:  Clin Interv Aging       Date:  2022-09-08       Impact factor: 3.829

4.  Hypophosphatemia promotes lower rates of muscle ATP synthesis.

Authors:  Dominik H Pesta; Dimitrios N Tsirigotis; Douglas E Befroy; Daniel Caballero; Michael J Jurczak; Yasmeen Rahimi; Gary W Cline; Sylvie Dufour; Andreas L Birkenfeld; Douglas L Rothman; Thomas O Carpenter; Karl Insogna; Kitt Falk Petersen; Clemens Bergwitz; Gerald I Shulman
Journal:  FASEB J       Date:  2016-06-23       Impact factor: 5.191

5.  Fibroblast Growth Factor 23-Induced Hypophosphatemia in Acute Leukemia.

Authors:  Rachel B Reinert; Dale Bixby; Ronald J Koenig
Journal:  J Endocr Soc       Date:  2018-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.